SCHEMBL30018135

SCHEMBL30018135

COc1cc(F)cc(-c2cncnc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 3/20 0.55
▸ CYP1B1 Q16678 3/20 0.55
▸ KDM1A O60341 1/20 0.43
▸ LRRK2 Q5S007 2/20 0.41
▸ ERN1 O75460 1/20 0.40
▸ PGR P06401 2/20 0.39
▸ CYP11B1 P15538 6/20 0.39
▸ CYP11B2 P19099 6/20 0.39
▸ CYP17A1 P05093 2/20 0.39
▸ CYP1A2 P05177 4/20 0.38
▸ CYP3A4 P08684 4/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2E1 P05181 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP4B1 P13584 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP3A5 P20815 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27859257 1.00 CYP1A1 (0.55) CYP1A1CYP1B1KDM1ALRRK2ERN1
SCHEMBL1898066 0.80 CYP1A1 (0.44) CYP1A1CYP1B1KDM1ALRRK2PGR
SCHEMBL13362350 0.80 CYP11B2 (0.56) CYP1A1CYP1B1ERN1CYP11B1CYP11B2
SCHEMBL30338748 0.80 CYP11B2 (0.56) CYP1A1CYP1B1ERN1CYP11B1CYP11B2
SCHEMBL30338912 0.76 CYP1A1 (0.63) CYP1A1CYP1B1CYP11B1CYP11B2CYP17A1
SCHEMBL24785334 0.75 KDM1A (0.41) CYP1A1CYP1B1KDM1ALRRK2PGR
SCHEMBL30103004 0.75 KDM1A (0.41) CYP1A1CYP1B1KDM1ALRRK2PGR
SCHEMBL24785335 0.75 KDM1A (0.41) CYP1A1CYP1B1KDM1ALRRK2PGR
SCHEMBL6606854 0.73 CYP1A1 (0.55) CYP1A1CYP1B1KDM1APGRCYP1A2
SCHEMBL22044476 0.73 KDM4E (0.55) CYP1A1CYP1B1KDM1ALRRK2PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022257960-A1 BICYCLIC COMPOUND FOR THE TREATMENT OF EP2 AND EP4 RECEPTOR-MEDIATED DISEASES 武汉人福创新药物研发中心有限公司 2022-12-15 — — WO disclosed
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 — — CN disclosed
Send feedback